{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:44:21Z","timestamp":1778031861259,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jsat.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T09:17:02Z","timestamp":1485335822000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee"],"prefix":"10.1016","volume":"76","author":[{"given":"Katie L.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi L.","family":"Puet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Hild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.01.005_bb0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","article-title":"Clinically significant pharmacokinetic interactions between dietary caffeine and medications","volume":"39","author":"Carrillo","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.jsat.2017.01.005_bb0020","author":"Center for Behavioral Health Statistics and Quality"},{"key":"10.1016\/j.jsat.2017.01.005_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/jhg.2012.139","article-title":"OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study","volume":"58","author":"Chen","year":"2013","journal-title":"Journal of Human Genetics"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2017.01.005_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(96)01331-2","article-title":"Smoking habits and attitudes in a methadone maintenance treatment population","volume":"44","author":"Clemmey","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2017.01.005_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2010.01.006","article-title":"Gabapentin improves cold-pressor pain responses in methadone-maintained patients","volume":"109","author":"Compton","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.01.005_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1384.037","article-title":"Interpretation of oral fluid tests for drugs of abuse","volume":"1098","author":"Cone","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2017.01.005_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: A national cohort study","volume":"111","author":"Cousins","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2017.01.005_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","article-title":"Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study","volume":"41","author":"Cousins","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.01.005_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2017.01.005_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"H\u00e4kkinen","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jsat.2017.01.005_bb0080","doi-asserted-by":"crossref","unstructured":"Heltsley, R., Depriest, A., Black, D. L., Crouch, D. J., Robert, T., Marshall, L., \u2026 Cone, E. J. (2012). Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. Journal of Analytical Toxicology, 36(2), 75\u201380. DOI: 10.1093\/jat\/bkr019","DOI":"10.1093\/jat\/bkr019"},{"issue":"8","key":"10.1016\/j.jsat.2017.01.005_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/anatox\/35.8.529","article-title":"Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs","volume":"35","author":"Heltsley","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsat.2014.07.003","article-title":"Denial of urinalysis-confirmed opioid use in prescription opioid dependence","volume":"48","author":"Hilario","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1081\/BIP-100101174","article-title":"Estimating sample sizes for continuous, binary, and ordinal outcomes in paired comparisons: Practical hints","volume":"9","author":"Julious","year":"1999","journal-title":"Journal of Biopharmaceutical Statistics"},{"issue":"5","key":"10.1016\/j.jsat.2017.01.005_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0110","first-page":"61","article-title":"Trends in drug use from urine drug testing of addiction treatment clients","volume":"11","author":"Kirsh","year":"2015","journal-title":"Journal of Opioid Management"},{"issue":"5","key":"10.1016\/j.jsat.2017.01.005_bb0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.5055\/jom.2015.0293","article-title":"Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction","volume":"11","author":"Kunkel","year":"2015","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.jsat.2017.01.005_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.jsat.2017.01.005_bb0130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/01612840.2015.1074769","article-title":"From resistance to existence\u2014Experiences of medication-assisted treatment as disclosed by people with opioid dependence","volume":"36","author":"Lindgren","year":"2015","journal-title":"Issues in Mental Health Nursing"},{"issue":"5","key":"10.1016\/j.jsat.2017.01.005_bb0135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199710000-00012","article-title":"Gabapentin abuse in a cocaine user: Implications for treatment?","volume":"17","author":"Markowitz","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2017.01.005_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fct.2013.10.042","article-title":"Beverage caffeine intakes in the U.S.","volume":"63","author":"Mitchell","year":"2014","journal-title":"Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association"},{"issue":"11","key":"10.1016\/j.jsat.2017.01.005_bb0145","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.addbeh.2006.01.006","article-title":"Cigarette smoking and interest in quitting in methadone maintenance patients","volume":"31","author":"Nahvi","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.jsat.2017.01.005_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4088\/JCP.v68n0320a","article-title":"Gabapentin abuse, and delirium tremens upon gabapentin withdrawal","volume":"68","author":"Pittenger","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2017.01.005_bb0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/10550490490460300","article-title":"Gabapentin abuse in inmates with prior history of cocaine dependence","volume":"13","author":"Reccoppa","year":"2004","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2105\/AJPH.91.2.296","article-title":"Tobacco use and quit attempts among methadone maintenance clients","volume":"91","author":"Richter","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2017.01.005_bb0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2296-10-42","article-title":"Prevalence of problem alcohol use among patients attending primary care for methadone treatment","volume":"10","author":"Ryder","year":"2009","journal-title":"BMC Family Practice"},{"issue":"5","key":"10.1016\/j.jsat.2017.01.005_bb0170","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0b013e31822bb378","article-title":"Importance of gabapentin dose in treatment of opioid withdrawal","volume":"31","author":"Salehi","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jsat.2017.01.005_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1521-0391.2013.12044.x","article-title":"Impact of cannabis use during stabilization on methadone maintenance treatment","volume":"22","author":"Scavone","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.jsat.2017.01.005_bb0180","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2017.01.005_bb0005","series-title":"Federal guidelines for opioid treatment programs. HHS publication no. (SMA) PEP15-FEDGUIDEOTP","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"issue":"2","key":"10.1016\/j.jsat.2017.01.005_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13556210020040217","article-title":"The effect of tobacco smoking on subjective symptoms of inadequacy (\u201cnot holding\u201d) of methadone dose among opiate addicts in methadone maintenance treatment","volume":"6","author":"Tacke","year":"2001","journal-title":"Addiction Biology"},{"issue":"4","key":"10.1016\/j.jsat.2017.01.005_bb0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2015.07.031","article-title":"Methadone's effect on nAChRs\u2014A link between methadone use and smoking?","volume":"97","author":"Talka","year":"2015","journal-title":"Biochemical Pharmacology"},{"issue":"94","key":"10.1016\/j.jsat.2017.01.005_bb0195","first-page":"28101","article-title":"Mandatory guidelines for federal workplace drug testing programs","volume":"80","author":"U.S. Department of Health and Human Services","year":"2015","journal-title":"Federal Register"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2006-958522","article-title":"Abuse, dependency and withdrawal with gabapentin: A first case report","volume":"40","author":"Victorri-Vigneau","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/anatox\/35.1.32","article-title":"Oral fluid is a viable alternative for monitoring drug abuse: Detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine","volume":"35","author":"Vindenes","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/j.jsat.2017.01.005_bb0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0000000000000076","article-title":"Caffeine-induced psychiatric manifestations: A review","volume":"30","author":"Wang","year":"2015","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jsat.2017.01.005_bb0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":"Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs","volume":"31","author":"Wille","year":"2009","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jsat.2017.01.005_bb0220","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"issue":"1","key":"10.1016\/j.jsat.2017.01.005_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13643-016-0317-2","article-title":"Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: A systematic review protocol","volume":"5","author":"Zielinski","year":"2016","journal-title":"Systematic Reviews"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:45:17Z","timestamp":1760039117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216304275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":45,"alternative-id":["S0740547216304275"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.01.005","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}